Market Exclusive

Bristol-Myers Squibb Company (NYSE:BMY) reported earnings of $0.74 per share beating Walls Streets expectations.

Bristol-Myers Squibb Company (NYSE:BMY) reported Q2 2017 earnings this Morning, coming in at $0.74 per share, beating Wall Street’s estimates of $0.73 per Share. Revenue for the quarter came in at $5.14 billion beating analyst estimates of $5.09 billion

Analyst Coverage For Bristol-Myers Squibb Company (NYSE:BMY)
These are 1 Sell Rating, 10 Hold Ratings, 10 Buy Ratings .
The current consensus rating for Bristol-Myers Squibb Company (NYSE:BMY) is Hold (Score: 2.43) with a consensus target price of $63.06 , a potential (12.65% upside)Recent Insider Trading for Bristol-Myers Squibb Company (NYSE:BMY)

Dividend History for Bristol-Myers Squibb Company (NYSE:BMY)

Recent Trading for Bristol-Myers Squibb Company (NYSE:BMY) Shares of Bristol-Myers Squibb Company closed the previous trading session at 53.34 down -2.64 -4.72% with 8,049,264 shares trading hands.

Exit mobile version